Kobayashi Pharmaceutical Co Ltd - ESG Rating & Company Profile powered by AI
This page contains a questions and answers section about Kobayashi Pharmaceutical Co Ltd. This ESG rating for Kobayashi Pharmaceutical Co Ltd represents the company's transparency towards the United Nations Sustainable Development Goals. If you are employed by Kobayashi Pharmaceutical Co Ltd and you would like to licence your Sustainability rating, please contact us.
Kobayashi Pharmaceutical Co Ltd in the Personal Products industry gained a UN SDG ESG Transparency Score of 6.2; made up of an environmental score of 7.0, social score of 7.1 and governance score of 4.6.
6.2
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | AKD SA | 8.0 | High |
| 1 | Kao Corp | 8.0 | High |
| 58 | McPherson's Ltd | 6.4 | High |
| 58 | Beiersdorf AG | 6.4 | High |
| 60 | Kobayashi Pharmaceutical Co Ltd | 6.2 | High |
| 60 | Amorepacific Group | 6.2 | High |
| 60 | Asia Coal Ltd | 6.2 | High |
| ... | ... | ... | |
| 223 | Zhejiang Shouxiangu Pharmaceutical Co Ltd | 0.0 | Low |
| 223 | iPure Labs Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Kobayashi Pharmaceutical Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Kobayashi Pharmaceutical Co Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Kobayashi Pharmaceutical Co Ltd report the average age of the workforce?
Sign up for free to unlockDoes Kobayashi Pharmaceutical Co Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Kobayashi Pharmaceutical Co Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Kobayashi Pharmaceutical Co Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Kobayashi Pharmaceutical Co Ltd offer flexible work?
Sign up for free to unlockDoes Kobayashi Pharmaceutical Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Kobayashi Pharmaceutical Co Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Kobayashi Pharmaceutical Co Ltd conduct supply chain audits?
Sign up for free to unlockDoes Kobayashi Pharmaceutical Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Kobayashi Pharmaceutical Co Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Kobayashi Pharmaceutical Co Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Kobayashi Pharmaceutical Co Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Kobayashi Pharmaceutical Co Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Kobayashi Pharmaceutical Co Ltd disclose water use targets?
Sign up for free to unlockDoes Kobayashi Pharmaceutical Co Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Kobayashi Pharmaceutical Co Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Kobayashi Pharmaceutical Co Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Kobayashi Pharmaceutical Co Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Kobayashi Pharmaceutical Co Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Kobayashi Pharmaceutical Co Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Kobayashi Pharmaceutical Co Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Kobayashi Pharmaceutical Co Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Kobayashi Pharmaceutical Co Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Kobayashi Pharmaceutical Co Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Kobayashi Pharmaceutical Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Kobayashi Pharmaceutical Co Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Kobayashi Pharmaceutical Co Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Kobayashi Pharmaceutical Co Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Kobayashi Pharmaceutical Co Ltd disclose its waste policy?
Sign up for free to unlockDoes Kobayashi Pharmaceutical Co Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Kobayashi Pharmaceutical Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Kobayashi Pharmaceutical Co Ltd disclose energy use targets?
Sign up for free to unlockDoes Kobayashi Pharmaceutical Co Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Kobayashi Pharmaceutical Co Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Kobayashi Pharmaceutical Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells consumer products in Japan and internationally. The company provides products in the areas of healthcare, household products, skincare, and body warmers. It also offers Ammeltz, a topical analgesic; Inochi no Haha, a women's health medicine; Sarasaty lingerie soap; Bluelet Decoral, a toilet bowl cleaner and freshener; Naishitol, a Chinese medicine; Eaude Muge, a medicated lotion for preventing acne; Itoyoji, a dental floss pick; BreathCare, an oral breath freshener capsule; Eyebon, an eye wash; Netsusama sheet, a cooling gel sheet for forehead; Sawaday, a toilet air freshener; and deodorizing air freshener, lens cleaner, and oral hygiene products. Additionally, the company manufactures and sells pharmaceuticals, quasi-drugs, cosmetics, hygiene and paper products, health foods, and processed synthetic resin products; markets nutritional supplements and skin care products through website and over the phone; and sells skincare products, daily necessities, and health foods. Further, it engages in transportation, real estate management, and advertising planning and production businesses; and asset management. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.